Candel Therapeutics, Inc.CADLNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank67
3Y CAGR+1.3%
5Y CAGR+12.3%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+1.3%/yr
Annual compound
5Y CAGR
+12.3%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
202513.31+381.1%
20242.77+6.6%
20232.59-79.8%
202212.81-19.1%
202115.84+112.4%
20207.46-76.7%
201932.06-